CereVasc, Inc., a clinical-stage medical device company developing novel, minimally invasive treatments for neurological ...
BOSTON, Oct. 3, 2023 /PRNewswire/ -- CereVasc, Inc., a clinical-stage, medical device company developing novel treatments for neurological diseases, announced a milestone thirtieth patient received ...
In this Innovation Spotlight, Dan Levangie, president and chief executive officer of CereVasc, discusses a new treatment strategy for NPH using an endovascularly implantable CSF shunt that minimizes ...
Hydrocephalus is a condition where fluid builds up in the brain , causing increased pressure on the brain. The literal meaning of the disease is “water in the brain.” Cerebrospinal fluid normally ...
CereVasc, Inc. announced the completion of enrollment in its ETCHES 1 study of the company’s eShunt system for the treatm ...